BioMarin Pharmaceutical Inc. buy Wells Fargo & Company
Start price
25.04.24
/
50%
€77.00
Target price
25.04.25
€102.63
Performance (%)
-27.92%
End price
26.04.25
€55.50
Summary
This prediction ended on 26.04.25 with a price of €55.50. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -27.92%. Wells_Fargo___Compan has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.851% | -1.851% | -19.691% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
Comments by Wells_Fargo___Compan for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Wells Fargo & Company from $100.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.07
28.10.25
28.10.25
€60.05
28.10.26
28.10.26
10.48%
30.12.25
30.12.25
Stopped prediction by Wells_Fargo___Compan for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.04
17.09.24
17.09.24
€80.92
17.09.25
17.09.25
-27.97%
18.09.25
18.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.46
27.06.24
27.06.24
€107.36
27.06.25
27.06.25
-39.27%
28.06.25
28.06.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.32
15.11.23
15.11.23
€92.05
15.11.24
15.11.24
-24.98%
16.11.24
16.11.24